COVID-19 Impact on Global Sulfonamides Market Size, Status and Forecast 2020-2026

July 2020 | 96 pages | ID: CADED16578E2EN
QYResearch

Abstracts

This report focuses on the global Sulfonamides status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Sulfonamides development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Pfizer
• Sanofi
• Roche
• Mylan
• Teva
• Bayer
• Abbott
• GlaxoSmithKline
• Boehringer Ingelheim

Market segment by Type, the product can be split into

• Intestinal Absorption
• Intestinal Tract Difficult to Absorb
• External Use

Market segment by Application, split into

• Systemic Infection
• Intestinal Infection
• Burn Infection
• Other Infections

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Sulfonamides status, future forecast, growth opportunity, key market and key players.
• To present the Sulfonamides development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Sulfonamides are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Sulfonamides Revenue
1.4 Market Analysis by Type
  1.4.1 Global Sulfonamides Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Intestinal Absorption
  1.4.3 Intestinal Tract Difficult to Absorb
  1.4.4 External Use
1.5 Market by Application
  1.5.1 Global Sulfonamides Market Share by Application: 2020 VS 2026
  1.5.2 Systemic Infection
  1.5.3 Intestinal Infection
  1.5.4 Burn Infection
  1.5.5 Other Infections
1.6 Coronavirus Disease 2019 (Covid-19): Sulfonamides Industry Impact
  1.6.1 How the Covid-19 is Affecting the Sulfonamides Industry
    1.6.1.1 Sulfonamides Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Sulfonamides Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Sulfonamides Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Sulfonamides Market Perspective (2015-2026)
2.2 Sulfonamides Growth Trends by Regions
  2.2.1 Sulfonamides Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Sulfonamides Historic Market Share by Regions (2015-2020)
  2.2.3 Sulfonamides Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Sulfonamides Market Growth Strategy
  2.3.6 Primary Interviews with Key Sulfonamides Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Sulfonamides Players by Market Size
  3.1.1 Global Top Sulfonamides Players by Revenue (2015-2020)
  3.1.2 Global Sulfonamides Revenue Market Share by Players (2015-2020)
  3.1.3 Global Sulfonamides Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Sulfonamides Market Concentration Ratio
  3.2.1 Global Sulfonamides Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Sulfonamides Revenue in 2019
3.3 Sulfonamides Key Players Head office and Area Served
3.4 Key Players Sulfonamides Product Solution and Service
3.5 Date of Enter into Sulfonamides Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Sulfonamides Historic Market Size by Type (2015-2020)
4.2 Global Sulfonamides Forecasted Market Size by Type (2021-2026)

5 SULFONAMIDES BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Sulfonamides Market Size by Application (2015-2020)
5.2 Global Sulfonamides Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Sulfonamides Market Size (2015-2020)
6.2 Sulfonamides Key Players in North America (2019-2020)
6.3 North America Sulfonamides Market Size by Type (2015-2020)
6.4 North America Sulfonamides Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Sulfonamides Market Size (2015-2020)
7.2 Sulfonamides Key Players in Europe (2019-2020)
7.3 Europe Sulfonamides Market Size by Type (2015-2020)
7.4 Europe Sulfonamides Market Size by Application (2015-2020)

8 CHINA

8.1 China Sulfonamides Market Size (2015-2020)
8.2 Sulfonamides Key Players in China (2019-2020)
8.3 China Sulfonamides Market Size by Type (2015-2020)
8.4 China Sulfonamides Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Sulfonamides Market Size (2015-2020)
9.2 Sulfonamides Key Players in Japan (2019-2020)
9.3 Japan Sulfonamides Market Size by Type (2015-2020)
9.4 Japan Sulfonamides Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Sulfonamides Market Size (2015-2020)
10.2 Sulfonamides Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Sulfonamides Market Size by Type (2015-2020)
10.4 Southeast Asia Sulfonamides Market Size by Application (2015-2020)

11 INDIA

11.1 India Sulfonamides Market Size (2015-2020)
11.2 Sulfonamides Key Players in India (2019-2020)
11.3 India Sulfonamides Market Size by Type (2015-2020)
11.4 India Sulfonamides Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Sulfonamides Market Size (2015-2020)
12.2 Sulfonamides Key Players in Central & South America (2019-2020)
12.3 Central & South America Sulfonamides Market Size by Type (2015-2020)
12.4 Central & South America Sulfonamides Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Pfizer
  13.1.1 Pfizer Company Details
  13.1.2 Pfizer Business Overview and Its Total Revenue
  13.1.3 Pfizer Sulfonamides Introduction
  13.1.4 Pfizer Revenue in Sulfonamides Business (2015-2020))
  13.1.5 Pfizer Recent Development
13.2 Sanofi
  13.2.1 Sanofi Company Details
  13.2.2 Sanofi Business Overview and Its Total Revenue
  13.2.3 Sanofi Sulfonamides Introduction
  13.2.4 Sanofi Revenue in Sulfonamides Business (2015-2020)
  13.2.5 Sanofi Recent Development
13.3 Roche
  13.3.1 Roche Company Details
  13.3.2 Roche Business Overview and Its Total Revenue
  13.3.3 Roche Sulfonamides Introduction
  13.3.4 Roche Revenue in Sulfonamides Business (2015-2020)
  13.3.5 Roche Recent Development
13.4 Mylan
  13.4.1 Mylan Company Details
  13.4.2 Mylan Business Overview and Its Total Revenue
  13.4.3 Mylan Sulfonamides Introduction
  13.4.4 Mylan Revenue in Sulfonamides Business (2015-2020)
  13.4.5 Mylan Recent Development
13.5 Teva
  13.5.1 Teva Company Details
  13.5.2 Teva Business Overview and Its Total Revenue
  13.5.3 Teva Sulfonamides Introduction
  13.5.4 Teva Revenue in Sulfonamides Business (2015-2020)
  13.5.5 Teva Recent Development
13.6 Bayer
  13.6.1 Bayer Company Details
  13.6.2 Bayer Business Overview and Its Total Revenue
  13.6.3 Bayer Sulfonamides Introduction
  13.6.4 Bayer Revenue in Sulfonamides Business (2015-2020)
  13.6.5 Bayer Recent Development
13.7 Abbott
  13.7.1 Abbott Company Details
  13.7.2 Abbott Business Overview and Its Total Revenue
  13.7.3 Abbott Sulfonamides Introduction
  13.7.4 Abbott Revenue in Sulfonamides Business (2015-2020)
  13.7.5 Abbott Recent Development
13.8 GlaxoSmithKline
  13.8.1 GlaxoSmithKline Company Details
  13.8.2 GlaxoSmithKline Business Overview and Its Total Revenue
  13.8.3 GlaxoSmithKline Sulfonamides Introduction
  13.8.4 GlaxoSmithKline Revenue in Sulfonamides Business (2015-2020)
  13.8.5 GlaxoSmithKline Recent Development
13.9 Boehringer Ingelheim
  13.9.1 Boehringer Ingelheim Company Details
  13.9.2 Boehringer Ingelheim Business Overview and Its Total Revenue
  13.9.3 Boehringer Ingelheim Sulfonamides Introduction
  13.9.4 Boehringer Ingelheim Revenue in Sulfonamides Business (2015-2020)
  13.9.5 Boehringer Ingelheim Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Sulfonamides Key Market Segments
Table 2. Key Players Covered: Ranking by Sulfonamides Revenue
Table 3. Ranking of Global Top Sulfonamides Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Sulfonamides Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Intestinal Absorption
Table 6. Key Players of Intestinal Tract Difficult to Absorb
Table 7. Key Players of External Use
Table 8. COVID-19 Impact Global Market: (Four Sulfonamides Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Sulfonamides Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Sulfonamides Players to Combat Covid-19 Impact
Table 13. Global Sulfonamides Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Sulfonamides Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Sulfonamides Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Sulfonamides Market Share by Regions (2015-2020)
Table 17. Global Sulfonamides Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Sulfonamides Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Sulfonamides Market Growth Strategy
Table 23. Main Points Interviewed from Key Sulfonamides Players
Table 24. Global Sulfonamides Revenue by Players (2015-2020) (Million US$)
Table 25. Global Sulfonamides Market Share by Players (2015-2020)
Table 26. Global Top Sulfonamides Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sulfonamides as of 2019)
Table 27. Global Sulfonamides by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Sulfonamides Product Solution and Service
Table 30. Date of Enter into Sulfonamides Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Sulfonamides Market Size by Type (2015-2020) (Million US$)
Table 33. Global Sulfonamides Market Size Share by Type (2015-2020)
Table 34. Global Sulfonamides Revenue Market Share by Type (2021-2026)
Table 35. Global Sulfonamides Market Size Share by Application (2015-2020)
Table 36. Global Sulfonamides Market Size by Application (2015-2020) (Million US$)
Table 37. Global Sulfonamides Market Size Share by Application (2021-2026)
Table 38. North America Key Players Sulfonamides Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Sulfonamides Market Share (2019-2020)
Table 40. North America Sulfonamides Market Size by Type (2015-2020) (Million US$)
Table 41. North America Sulfonamides Market Share by Type (2015-2020)
Table 42. North America Sulfonamides Market Size by Application (2015-2020) (Million US$)
Table 43. North America Sulfonamides Market Share by Application (2015-2020)
Table 44. Europe Key Players Sulfonamides Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Sulfonamides Market Share (2019-2020)
Table 46. Europe Sulfonamides Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Sulfonamides Market Share by Type (2015-2020)
Table 48. Europe Sulfonamides Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Sulfonamides Market Share by Application (2015-2020)
Table 50. China Key Players Sulfonamides Revenue (2019-2020) (Million US$)
Table 51. China Key Players Sulfonamides Market Share (2019-2020)
Table 52. China Sulfonamides Market Size by Type (2015-2020) (Million US$)
Table 53. China Sulfonamides Market Share by Type (2015-2020)
Table 54. China Sulfonamides Market Size by Application (2015-2020) (Million US$)
Table 55. China Sulfonamides Market Share by Application (2015-2020)
Table 56. Japan Key Players Sulfonamides Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Sulfonamides Market Share (2019-2020)
Table 58. Japan Sulfonamides Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Sulfonamides Market Share by Type (2015-2020)
Table 60. Japan Sulfonamides Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Sulfonamides Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players Sulfonamides Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players Sulfonamides Market Share (2019-2020)
Table 64. Southeast Asia Sulfonamides Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia Sulfonamides Market Share by Type (2015-2020)
Table 66. Southeast Asia Sulfonamides Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia Sulfonamides Market Share by Application (2015-2020)
Table 68. India Key Players Sulfonamides Revenue (2019-2020) (Million US$)
Table 69. India Key Players Sulfonamides Market Share (2019-2020)
Table 70. India Sulfonamides Market Size by Type (2015-2020) (Million US$)
Table 71. India Sulfonamides Market Share by Type (2015-2020)
Table 72. India Sulfonamides Market Size by Application (2015-2020) (Million US$)
Table 73. India Sulfonamides Market Share by Application (2015-2020)
Table 74. Central & South America Key Players Sulfonamides Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players Sulfonamides Market Share (2019-2020)
Table 76. Central & South America Sulfonamides Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America Sulfonamides Market Share by Type (2015-2020)
Table 78. Central & South America Sulfonamides Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America Sulfonamides Market Share by Application (2015-2020)
Table 80. Pfizer Company Details
Table 81. Pfizer Business Overview
Table 82. Pfizer Product
Table 83. Pfizer Revenue in Sulfonamides Business (2015-2020) (Million US$)
Table 84. Pfizer Recent Development
Table 85. Sanofi Company Details
Table 86. Sanofi Business Overview
Table 87. Sanofi Product
Table 88. Sanofi Revenue in Sulfonamides Business (2015-2020) (Million US$)
Table 89. Sanofi Recent Development
Table 90. Roche Company Details
Table 91. Roche Business Overview
Table 92. Roche Product
Table 93. Roche Revenue in Sulfonamides Business (2015-2020) (Million US$)
Table 94. Roche Recent Development
Table 95. Mylan Company Details
Table 96. Mylan Business Overview
Table 97. Mylan Product
Table 98. Mylan Revenue in Sulfonamides Business (2015-2020) (Million US$)
Table 99. Mylan Recent Development
Table 100. Teva Company Details
Table 101. Teva Business Overview
Table 102. Teva Product
Table 103. Teva Revenue in Sulfonamides Business (2015-2020) (Million US$)
Table 104. Teva Recent Development
Table 105. Bayer Company Details
Table 106. Bayer Business Overview
Table 107. Bayer Product
Table 108. Bayer Revenue in Sulfonamides Business (2015-2020) (Million US$)
Table 109. Bayer Recent Development
Table 110. Abbott Company Details
Table 111. Abbott Business Overview
Table 112. Abbott Product
Table 113. Abbott Revenue in Sulfonamides Business (2015-2020) (Million US$)
Table 114. Abbott Recent Development
Table 115. GlaxoSmithKline Business Overview
Table 116. GlaxoSmithKline Product
Table 117. GlaxoSmithKline Company Details
Table 118. GlaxoSmithKline Revenue in Sulfonamides Business (2015-2020) (Million US$)
Table 119. GlaxoSmithKline Recent Development
Table 120. Boehringer Ingelheim Company Details
Table 121. Boehringer Ingelheim Business Overview
Table 122. Boehringer Ingelheim Product
Table 123. Boehringer Ingelheim Revenue in Sulfonamides Business (2015-2020) (Million US$)
Table 124. Boehringer Ingelheim Recent Development
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Sulfonamides Market Share by Type: 2020 VS 2026
Figure 2. Intestinal Absorption Features
Figure 3. Intestinal Tract Difficult to Absorb Features
Figure 4. External Use Features
Figure 5. Global Sulfonamides Market Share by Application: 2020 VS 2026
Figure 6. Systemic Infection Case Studies
Figure 7. Intestinal Infection Case Studies
Figure 8. Burn Infection Case Studies
Figure 9. Other Infections Case Studies
Figure 10. Sulfonamides Report Years Considered
Figure 11. Global Sulfonamides Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Sulfonamides Market Share by Regions: 2020 VS 2026
Figure 13. Global Sulfonamides Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Sulfonamides Market Share by Players in 2019
Figure 16. Global Top Sulfonamides Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sulfonamides as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Sulfonamides Revenue in 2019
Figure 18. North America Sulfonamides Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Sulfonamides Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Sulfonamides Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Sulfonamides Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Sulfonamides Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Sulfonamides Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Sulfonamides Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Pfizer Revenue Growth Rate in Sulfonamides Business (2015-2020)
Figure 27. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Sanofi Revenue Growth Rate in Sulfonamides Business (2015-2020)
Figure 29. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Roche Revenue Growth Rate in Sulfonamides Business (2015-2020)
Figure 31. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Mylan Revenue Growth Rate in Sulfonamides Business (2015-2020)
Figure 33. Teva Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Teva Revenue Growth Rate in Sulfonamides Business (2015-2020)
Figure 35. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Bayer Revenue Growth Rate in Sulfonamides Business (2015-2020)
Figure 37. Abbott Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Abbott Revenue Growth Rate in Sulfonamides Business (2015-2020)
Figure 39. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. GlaxoSmithKline Revenue Growth Rate in Sulfonamides Business (2015-2020)
Figure 41. Boehringer Ingelheim Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Boehringer Ingelheim Revenue Growth Rate in Sulfonamides Business (2015-2020)
Figure 43. Bottom-up and Top-down Approaches for This Report
Figure 44. Data Triangulation
Figure 45. Key Executives Interviewed